CAVION INC has a total of 39 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are INST MALGACHE DE RECH S APPLIQ, AICURIS ANTI INFECTIVE CURES GMBH and BORYUNG PHARM.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United States | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | China | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Singapore | 3 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Electrotherapy | |
#6 | Peptides | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Maricich Yuri | 21 |
#2 | Macdonald Timothy | 12 |
#3 | Newbold Evan | 12 |
#4 | Higgin Michelle | 7 |
#5 | Richardson Thomas E | 7 |
#6 | Gray Lloyd S | 6 |
#7 | Linden Joel | 4 |
#8 | Duvvuri Muralikrishna | 3 |
#9 | Krouse Andrew J | 3 |
#10 | Higgin Michelle S | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021067697A1 | Methods and materials for treating neurotoxicity | |
CA3115235A1 | Treating essential tremor using (r)-2-(4-isopropylphenyl)-n-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide | |
SG11201909963YA | Methods for treating dravet syndrome | |
EP3615521A1 | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
CA3053781A1 | Calcium channel inhibitors | |
EP3364993A1 | Methods for treating angelman syndrome and related disorders | |
AU2012309800A1 | Antagonists of products of the Hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells |